Results 141 to 150 of about 34,994 (236)

The role of FGFR signaling in SCLC and NSCLC: Current insights and therapeutic perspectives. [PDF]

iScience
Kim BC, Lee GT, Jeong M, Choi HJ, Kim KB.   +4 more
europepmc   +1 more source

Persistent FGFR pathway dependence: where does tinengotinib fit after FGFR inhibitor therapy in advanced cholangiocarcinoma? [PDF]

J Gastrointest Oncol
Sasanuma H, Yamaguchi H.
europepmc   +1 more source

Combination effect of arsenic trioxide and FGFR inhibitor through downregulation of FGFR, Akt and Erk in squamous cell lung carcinoma

, 2014
Background: Lung cancer is the top cancer killer. Squamous cell lung carcinoma (SCC) represents the second most common histologic subtype of lung cancer.
Lam, SK, Li, Y, Zheng, C, Leung, LL, Ho, JCM   +4 more
core  

Reprogramming FGFR isoform specificity in FGF2 by deep mutational scanning. [PDF]

Chem Sci
Okada Y, Morimoto J, Sando S.
europepmc   +1 more source

Signaling by FGFR

Reactome - a curated knowledgebase of biological pathways, 2007
openaire   +1 more source

Fibroblast growth factor receptor 1 status discordance between primary breast tumours and lymph node metastases is associated with peripheral blood circulating tumour cell burden. [PDF]

Contemp Oncol (Pozn)
Braun M, Czerwiński J, Richert J, Sołek J, Paprocki D, Labuk T, Maj M, Panek CA, Piasecka D, Chrobak-Bień JZ, Nejc D, Piastowska-Ciesielska AW, Kordek R, Bednarz-Knoll N, Sadej R, Romanska H.   +15 more
europepmc   +1 more source

Fibroblast growth factor receptor signaling in maturing osteoblasts controls cell-matrix interactions critical for osteocyte survival. [PDF]

Bone Res
Patra D, Smith C, Wei C, Mazur CM, Ameadaji I, Li T, Wein MN, Silva MJ, Ornitz DM.   +8 more
europepmc   +1 more source

FGF/FGFR signaling at the immune-stromal interface in autoimmune rheumatic diseases: from tissue remodeling to translational opportunities. [PDF]

Front Immunol
Zhong S, Meng X, Xiang Z, Qiu G, Sun S, Xie J, Xiao L.   +6 more
europepmc   +1 more source

Sequencing of Fibroblast Growth Factor Receptor Inhibitors in Cholangiocarcinoma: A Review of Published Cases. [PDF]

JCO Precis Oncol
Dilg D, Blecker M, Vivancos A, Macarulla T, Vogel A.   +4 more
europepmc   +1 more source

Clinical response to FGFR inhibitors in patients with FGFR2-amplified advanced gastric cancer: two case reports. [PDF]

Front Oncol
Li JJ, Qian Y, Xu HT, Nie YL.
europepmc   +1 more source